Trevi Therapeutics, Inc.TRVINASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank56
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P56
Within normal range
vs 3Y Ago
-3.8x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025-10.02%
2024-20.64%
2023-12.55%
20222.66%
20210.19%
2020-25.58%
2019-26.25%
2018-129.35%
201728.74%
20160.00%